CCM
BRKRP

Callodine Capital Management’s Bruker Corporation 6.375% Series A Preferred Stock BRKRP Stock Holding History

Callodine Capital Management’s Portfolio BRKRP Stock Details BRKRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,000
Closed -$10.9M – 62
2025
Q3 		$10.9M Buy
+40,000
New +$10.7M 0.95% 33

Other funds holding BRKRP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $6.43B AUM 16.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return

Callodine Capital Management's BRKRP Position: Q4 2025 in Review

Callodine Capital Management sold out of Bruker Corporation 6.375% Series A Preferred Stock (BRKRP) in Q4 2025, closing a stake of 40,000 shares — an estimated $10.9M sold.

Callodine Capital Management first reported a position in BRKRP in Q3 2025 and held it in 1 quarter. The position peaked at $10.9M in Q3 2025. 33 funds tracked by Wall St. Rank hold BRKRP as of Q4 2025.

  • Callodine Capital Management reported no remaining Bruker Corporation 6.375% Series A Preferred Stock position as of Q4 2025 after selling out during the quarter.
  • Callodine Capital Management sold 40,000 Bruker Corporation 6.375% Series A Preferred Stock shares in Q4 2025, an estimated $10.9M.
  • Callodine Capital Management first reported a position in Bruker Corporation 6.375% Series A Preferred Stock in Q3 2025 and held it in 1 quarter.
  • Callodine Capital Management's Bruker Corporation 6.375% Series A Preferred Stock position peaked at $10.9M in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Bruker Corporation 6.375% Series A Preferred Stock as of Q4 2025.

Based on Callodine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.